OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

BCEL

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

Atreca (BCEL) Ownership - Who owns Atreca?

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

835 Industrial Road

Phone

+1 650 595-2595

Employees

Web

https://www.atreca.com

Details

Group

Domestic Stock Funds

Fundamentals

BCEL

Capitalization

N/A

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

N/A

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

N/A

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response.

Industry Biotechnology